Navigation Links
Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases
Date:9/25/2010

DULUTH, Minn., Sept. 25 /PRNewswire/ -- CSL Plasma, one of the world's largest collectors of human plasma, is honoring donors from the Duluth area today as part of a statewide observance of "Plasma Protein Therapies Month."

According to Randy Furby, Senior Vice President and General Manager of CSL Plasma, Plasma Protein Therapies Month is helping raise awareness of rare genetic diseases treated with plasma-derived therapies while recognizing the generous contributions of plasma donors in the state,

"Every year, thousands of people around the world with rare diseases depend upon therapies made from donated human plasma," Furby says. "These therapies treat people with hemophilia, von Willebrand's disease, immune disorders, hereditary angioedema, Alpha 1-antitrypsin deficiency and more." According to the Plasma Protein Therapeutics Association, approximately 8.5 million liters of source plasma are donated in the US every year.  

In addition to donors, invited guests to the event which is being held in CSL Plasma's collection center at 106 West Superior Street in Duluth include patients that benefit from plasma-derived therapies and local, state and federal elected officials.

Donors to address gatheringJohn and Mary Gerszewski, who met at the Duluth center in 2007 and married in 2008, will share their perspective which is representative of CSL Plasma donors. John has been donating plasma since 2005. "We know that it helps people," John says. "Mary and I are all about that."  

Helping people was also the motivation for John and Mary to expand their partnership beyond married life. The couple recently opened the Lifetime Wellness Center in Duluth where they help disabled and elderly clients stay fit and limber. "Hopefully we can help people maintain their independence and remain in their homes longer," John said.

Bringing patients, employees and donors togetherAccording to Allen Coleman, CSL Plasma's Divisional Director of Operations, CSL Plasma's innovative Adopt-a-Patient program brings donors, patients and CSL Plasma employees together. The program provides donors and employees with an opportunity to interact with patients to learn more about their therapy, while patients learn about the collection process and the quality standards used to collect the safest, highest quality plasma.

Economic Impact Coleman also points to the impact of the plasma center, which is staffed by 51 full-time and 14 part-time employees from the Duluth area, on the local economy. "Employee salaries and wages total over $1.5 million annually," Coleman says. "In addition, we collect 100,000 donations a year for which Duluth-area donors receive over $3 million."  

While the total amount of dollars that are annually infused in the Duluth economy not including state and local taxes is more than $4.5 million, John Gerszewski says it best: it's all about people.

Headquartered in Boca Raton, Florida, CSL Plasma is a wholly owned subsidiary of CSL Behring, a global leader in the research, development and manufacture of lifesaving therapies used to treat rare and serious diseases. Contact:Chris FlorentzManager, Corporate Communications610-878-4316Christopher.Florentz@cslbehring.com
'/>"/>

SOURCE CSL Plasma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
3. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
4. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
5. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
6. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
7. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
8. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
9. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
10. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
11. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):